Testing effectiveness (Phase 2)Study completedNCT04300296
What this trial is testing
PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus
Who this might be right for
Lichen Planus: Cutaneous Lichen Planus, Mucosal Lichen Planus and Lichen Planopilaris
Novartis Pharmaceuticals 111